Latest Breaking News On - Stone endowed professor - Page 1 : comparemela.com

Tenax Therapeutics to Host KOL Event: "LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study"

Tenax Therapeutics to Host KOL Event: "LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study"
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Columbia universityNew yorkUnited statesJohns hopkins hospitalAmerican college of cardiologyCity of new yorkMayo clinic in rochesterHarvard universitySanjiv shahPatrickh lehanJaved butlerDaniel burkhoffCharlesa garganoJohn frauncesmanaging directorlifesciBaylor scott white research instituteInternational society for heart

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesChris giordanoSanjivj shahBrian mullenJohn frauncesSanjiv shahResearch for the bluhm cardiovascular instituteCardiovascular research foundation technologyOrion corporationTenax therapeutics incLifesci advisorsNasdaq stock marketCardiovascular research foundationHeart failure therapeuticsHeart failureStone endowed professor

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJohn frauncesmanaging directorlifesciSanjiv shahChris giordanoSanjivj shahNasdaq stock marketOrion corporationResearch for the bluhm cardiovascular instituteTenax therapeutics incCardiovascular research foundation technologyCardiovascular research foundationHeart failure therapeuticsHeart failureStone endowed professorBluhm cardiovascular instituteNorthwestern university feinberg school

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024

29.02.2024 - Dr. Sanjiv Shah, a renowned, global expert in the treatment of HFpEF and PH-HFpEF, will present data highlighting the use of levosimendan for the treatment of pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) . Seite 1

United statesSanjiv shahChris giordanoSanjivj shahResearch for the bluhm cardiovascular instituteCardiovascular research foundation technologyTenax therapeutics incHeart failureStone endowed professorBluhm cardiovascular instituteNorthwestern university feinberg schoolCardiovascular research foundationHeart failure therapeuticsConcurrent sessionWestin boston seaportChief executive officer